As the 3 mg liraglutide product is approved for chronic weight management, it seems reasonable for patients to continue therapy until they have lost 5 to 10% of their baseline body weight and potentially longer if there is evidence of further and/or durable weight loss associated with treatment
Athletic studies showed better muscle oxygen with glutathione supplementation
On Monday, the FDA approved a pill version of Wegovy, which will hit the market in January
However, its effects on growth hormone, IGF-1, sleep, and metabolic health can create a hormonal environment that supports better testosterone function
This was a state Medicaid policy decision, not a UPMC formulary decision
Can Victoza help with weight loss